These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2493690)

  • 21. Effects of a new thyrotropin releasing hormone analogue, YM-14673, on the in vivo release of acetylcholine as measured by intracerebral dialysis in rats.
    Okada M
    J Neurochem; 1991 May; 56(5):1544-7. PubMed ID: 1901593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YM-14673, a new thyrotropin-releasing hormone analog, augments long-term potentiation in the mossy fiber-CA3 system of guinea pig hippocampal slices.
    Ishihara K; Katsuki H; Sugimura M; Satoh M
    J Pharmacobiodyn; 1992 Feb; 15(2):75-8. PubMed ID: 1403605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ataxia-ameliorating effects of YM-14673, a potent analog of thyrotropin releasing hormone, in ataxic mutant mice.
    Matsui K; Wada K; Kwak S
    Eur J Pharmacol; 1994 Mar; 254(3):295-7. PubMed ID: 8013566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of thyrotropin-releasing hormone analogue (YM14673) on experimental brain contusion and edema in rats].
    Zhang JJ; Zhang SD
    Yao Xue Xue Bao; 1996; 31(4):250-3. PubMed ID: 9208647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological and behavioral outcomes of focal cerebral ischemia in rats.
    Wahl F; Allix M; Plotkine M; Boulu RG
    Stroke; 1992 Feb; 23(2):267-72. PubMed ID: 1561657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticonvulsive properties of YM-14673, a new TRH analogue, in amygdaloid-kindled rats.
    Yatsugi S; Yamamoto M
    Pharmacol Biochem Behav; 1991 Mar; 38(3):669-72. PubMed ID: 2068205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of long-term administration of JTP-2942, a novel thyrotropin-releasing hormone analogue, on neurological outcome, local cerebral blood flow and glucose utilization in a rat focal cerebral ischemia.
    Katsumata T; Katayama Y; Ootori T; Muramatsu H; Nishiyama Y; Nakamura H; Seta T; Terashi A
    Brain Res; 2001 May; 901(1-2):62-70. PubMed ID: 11368951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral changes induced by the thyrotropin-releasing hormone analogue, RGH 2202.
    Drago F; Grassi M; Valerio C; Coppi G; Lauria N; Nicotra GC; Raffaele R
    Peptides; 1991; 12(6):1309-13. PubMed ID: 1815218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of YM-14673, a new thyrotropin releasing hormone analogue, on ataxic gait in cytosine arabinoside-treated mice.
    Yamamoto M; Shimizu M
    Eur J Pharmacol; 1989 Aug; 166(3):545-7. PubMed ID: 2509218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of YM-14673, an analogue of thyrotropin-releasing hormone, on duodenal bicarbonate secretion in the rat.
    Takeuchi K; Niida H; Ueshima K; Okabe S
    Arch Int Pharmacodyn Ther; 1991; 314():133-46. PubMed ID: 1824186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a motor deficit after chronic focal cerebral ischemia in rats.
    Yonemori F; Yamaguchi T; Yamada H; Tamura A
    J Cereb Blood Flow Metab; 1998 Oct; 18(10):1099-106. PubMed ID: 9778186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of RGH 2202 on cognitive and motor behavior of the rat.
    Drago F; Coppi G; Antonuzzo PA; Valerio C; Genazzani AA; Grassi M; Raffaele R; Scapagnini U
    Neurobiol Aging; 1996; 17(1):67-71. PubMed ID: 8786805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of indeloxazine hydrochloride on behavioral and biochemical changes in the chronic phase of focal cerebral ischemia in rats.
    Shimizu-Sasamata M; Yamamoto M; Okada M; Yamaguchi T; Tamura A
    Arch Int Pharmacodyn Ther; 1991; 314():74-89. PubMed ID: 1824190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat.
    Smith SE; Hodges H; Sowinski P; Man CM; Leach MJ; Sinden JD; Gray JA; Meldrum BS
    Neuroscience; 1997 Apr; 77(4):1123-35. PubMed ID: 9130792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NS-3 (CG3703), an analog of thyrotropin-releasing hormone, ameliorates cognitive impairment in rats.
    Ogasawara T; Ukai Y; Tamura M; Kimura K
    Pharmacol Biochem Behav; 1995 Apr; 50(4):499-503. PubMed ID: 7617693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral changes after focal cerebral ischemia by left middle cerebral artery occlusion in rats.
    Yamamoto M; Tamura A; Kirino T; Shimizu M; Sano K
    Brain Res; 1988 Jun; 452(1-2):323-8. PubMed ID: 3401738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies.
    Faden AI
    Brain Res; 1989 May; 486(2):228-35. PubMed ID: 2499400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YM796, a novel muscarinic agonist, improves the impairment of learning behavior in a rat model of chronic focal cerebral ischemia.
    Yamaguchi T; Suzuki M; Yamamoto M
    Brain Res; 1995 Jan; 669(1):107-14. PubMed ID: 7712153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat.
    Zhang RL; Zhang L; Jiang Q; Zhang ZG; Goussev A; Chopp M
    Brain Res; 2000 Sep; 878(1-2):64-71. PubMed ID: 10996136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.